Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Nov;24(11):701-4.
doi: 10.1002/clc.4960241103.

Interleukin-6 and acute coronary syndrome

U Ikeda  1 , T Ito, K Shimada
Affiliations

Interleukin-6 and acute coronary syndrome

U Ikeda et al. Clin Cardiol. 2001 Nov.

Abstract

The designation of atherosclerosis as a chronic inflammatory process represents an exciting and logical paradigm shift for cardiologists. Plasma concentrations of interleukin-6 (IL-6) and its hepatic by-product C-reactive protein (CRP) appear to reflect the intensity of occult plaque inflammation and by inference may determine vulnerability to rupture. Indeed, circulating IL-6 levels are elevated in patients with acute myocardial infarction (AMI), and also in patients with unstable, but not with stable angina. Coronary sinus IL-6 concentrations are also increased after percutaneous coronary intervention (PCI), and late restenosis correlates with an increase in IL-6 concentration after the procedure, indicating that IL-6 expression may be not only related to instability of atheromatous plaques, but also to the formation of restenotic lesions after PCI. These observations suggest the advantage of screening for circulating IL-6 concentration and the use of anti-inflammatory treatment for those thought be at high risk to reduce the risk of future AMI.

PubMed Disclaimer

References

    1. Neumann FJ, Ott I, Marx N, Luther T, Kenngott S, Gawaz M, Kotzsch M, Schomig A: Effect of human recombinant interleukin‐6 and interleukin‐8 on monocyte procoagulant activity. Arterioscler Thromb Vasc Biol 1997; 17: 3399–3405 - PubMed
    1. Hamanak R, Kohno K, Seguchi T, Okamura K, Morimoto T, Onon M, Ogata M, Kuwano M: Induction of low‐density lipoprotein receptor and transcription factor SP‐1 by tumor necrosis factor in human vascular endothelial cells. J Biol Chem 1992; 267: 13160–13165 - PubMed
    1. Galis ZS, Muszynski M, Sukhova GK, Simon‐Morrissey E, Unemori EN, Lark M, Amento E, Libby P: Cytokine‐stimulated smooth muscle cells stimulate a complement of enzymes required for extracellular matrix digestion. Circ Res 1994; 75: 181–189 - PubMed
    1. Biswas P, Delfanti F, Mengozzi M, Cota M, Polentarutti N, Matnovani A, Lazzarin A, Sozzani S, Poli G: Interleukin 6 induces monocyte chemotactic protein‐1 in peripheral blood mononuclear cells and in the U937 cell line. Blood 1998; 91: 258–265 - PubMed
    1. Ikeda U, Ikeda M, Seino Y, Takahashi M, Kasahara T, Kano S, Shimada K: Expression of intracellular adhesion molecule 1 in rat vascular smooth muscle cells by pro‐inflammatory cytokines. Atherosclerosis 1993; 104: 61–68 - PubMed